echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Haizheng Pfizer named Hanyu Pharmaceuticals "new" pharmaceutical company annual business of 3.9 billion

    Haizheng Pfizer named Hanyu Pharmaceuticals "new" pharmaceutical company annual business of 3.9 billion

    • Last Update: 2021-02-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    A new pharmaceutical company has been born!Haizheng Pfizer, named Hanyu Pharmaceuticals
    On June 29, Zhejiang Haizheng Pharmaceuticals issued a "Announcement on the Name Of the Holding Subsidiary".
    announced that its controlling subsidiary, Haizheng Pfizer Pharmaceuticals, has been approved by the Fuyang District Market Supervision Authority of Hangzhou City, the name changed to "Hanyu Pharmaceutical Co., Ltd." The relevant industrial and commercial registration change procedures have been completed, and obtained a new "business license."
    source close to Haizheng Pharmaceuticals told SaibaiLan that its employees yesterday (28) have received a formal name change notice, reimbursement bills, product information and other materials have been updated. The notice requires that the words "Pfizer" and LOGO will no longer be used in mail, PPT and various documents as of that date.""new" pharmaceutical company, annual revenue of 3.9 billion
    since then, the new peach "Hanyu Pharmaceuticals" replaced the old character "Hai Zheng Pfizer";
    haizheng and Pfizer's marriage officially ended on November 11, 2017, Haizheng Pharmaceuticals issued a "suggestive announcement on the change of equity of the controlling subsidiary Haizheng Pfizer Co., Ltd." Pfizer will no longer directly or indirectly hold any equity interest in Haizheng Pfizer after transferring its 49% stake in Haizheng Pfizer to GaoZheng Capital.
    is understood to be the largest private equity fund in Asia, with a focus on long-term structured value investments. Pfizer and Haizheng formed a joint venture on September 13, 2012, ending a five-year marriage.
    's 2017 annual report shows that Haizheng Pfizer's current independent marketing network covers 31 provinces (municipalities and autonomous regions) and more than 4,500 hospitals. Revenue for 2017 was $3.97 billion, with net profit attributable to the parent company of $480 million.joint venture change, in early August official Xuan
    on the name change of the enterprise, yesterday the author called Haizheng Pharmaceuticals, the other side of the announcement of information other than no comment. In fact, on June 1-2, at the 2nd MayoClinic China Hospital Management Summit in Shanghai, the materials on display were already the name of Hanyu Pharmaceuticals.
    people close to Haizheng Pharmaceuticals said the company's name change has been in full play, around the beginning of August will hold a press conference to officially put Hanyu Pharmaceuticals in public, including the replacement of packaging products, management composition, business operations planning and so on.
    's feelings about the replacement of the joint venture, the source did not disclose. (Seber Blue)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.